全球化学品在线数据库
| CAS 登录号 | 产品名称 | 分子式 |
|---|---|---|
| 1616632-77-9 | 2,4,6,7,8,9-Hexahydro-4-[(2-methylphenyl)methyl]-7-(phenylmethyl)imidazo[1,2-a]pyrido[3,4-e]pyrimidin-5(1H)-one | C24H26N4O |
| 1616703-93-5 | Ticagrelor EP Impurity C;2-(((1S,2S,3S,4R)-4-(7-(((1R,2S)-2-(3,4-difluorophenyl)cyclopropyl)amino)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-2,3-dihydroxycyclopentyl)oxy)ethyl acetate | C25H30F2N6O5S |
| 1616761-00-2 | (3R,4R)-3-[(2-Chloro-7H-pyrrolo[2,3-d]pyrimidin-4-yl)methylamino]-4-methyl-beta-oxo-1-piperidinepropanenitrile | C16H19ClN6O |
| 1616967-26-0 | Formoterol EP Impurity E;N-(2-hydroxy-5-(1-hydroxy-2-((2-(4-methoxy-3-methylphenyl)-1-methylethyl)amino)ethyl)phenyl)formamide | C20H26N2O4 |
| 1616979-93-1 | tert-Butylbis(3,5-di-tert-butylphenyl)phosphine | C32H51P |
| 1618657-31-0 | Ezetimibe Impurity 9;Xxzjuzxkbfupqh-ikggrygdsa-N; (2R,3R,6S)-6-(4-fluorophenyl)-2-(4-hydroxyphenyl)oxane-3-carboxylic acid | C18H17FO4 |
| 1619967-09-7 | (3,3'-Difluoro-[2,2'-bithiophene]-5,5'-diyl)bis(trimethylstannane);[4-fluoro-5-(3-fluoro-5-trimethylstannylthiophen-2-yl)thiophen-2-yl]-trimethylstannane | C14H20F2S2Sn2 |
| 1619994-68-1 | 1-[1-[2-(Methylsulfonyl)phenyl]-7-propoxy-3-indolizinyl]ethanone | C20H21NO4S |
| 1619994-69-2 | Ethyl (3-methyl-6-(4-methyl-3-(methylsulfonamido)phenyl)-[1,2,4]triazolo[4,3-b]pyridazin-8-yl)carbamate | C17H20N6O4S |
| 1620097-06-4 | (5R)-Hexahydro-5-methyl-1-(phenylmethyl)-1H-1,4-diazepine | C13H20N2 |
| 1620401-82-2 | 6,7-Dimethoxy-2-(1-pyrrolidinyl)-N-[5-(1-pyrrolidinyl)pentyl]-4-quinazolinamine | C23H35N5O2 |
| 1620458-09-4 | Zoliflodacin;(4'R,6'S,7'S)-17'-fluoro-4',6'-dimethyl-13'-[(4S)-4-methyl-2-oxo-1,3-oxazolidin-3-yl]spiro[1,3-diazinane-5,8'-5,15-dioxa-2,14-diazatetracyclo[8.7.0.02,7.012,16]heptadeca-1(17),10,12(16),13-tetraene]-2,4,6-trione | C22H22FN5O7 |
| 1620576-64-8 | 1-[4-[5-[5-Amino-6-(5-tert-butyl-1,3,4-oxadiazol-2-yl)pyrazin-2-yl]-1-ethyl-1H-1,2,4-triazol-3-yl]piperidin-1-yl]-3-hydroxypropan-1-one | C22H31N9O3 |
| 1621085-33-3 | 3-Methyl-N-[(phenylmethoxy)carbonyl]-L-valine compd. with 2-propanamine | C14H19NO4.C3H9N |
| 1621175-65-2 | N-[3-Chloro-4-[[[2-(methylamino)-6-(2-pyridinyl)-4-pyrimidinyl]amino]methyl]phenyl]methanesulfonamide | C18H19ClN6O2S |
| 1621274-17-6 | DPPF Pd G4;(SP-4-3)-[1-(Diphenylphosphino-?P)-1'-(diphenylphosphino)ferrocene](methanesulfonato-?O)[2'-(methylamino-?N)[1,1'-biphenyl]-2-yl-?C]palladium | C48H43FeNO3P2PdS |
| 1621274-19-8 | (SP-4-3)-[[5-(diphenylphosphino)-9,9-dimethyl-9H-xanthen-4-yl]diphenylphosphine-κP](methanesulfonato-κO)[2'-(methylamino-κN)[1,1'-biphenyl]-2-yl-κC]-Palladium;XantPhos Pd G4 | C53H47NO4P2PdS |
| 1621681-63-7 | Cabozantinib N-oxide;1-N-[4-(6,7-dimethoxy-1-oxidoquinolin-1-ium-4-yl)oxyphenyl]-1-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide | C28H24FN3O6 |
| 1622008-73-4 | 4,4'-(2,3-Dihydrothieno[3,4-b]-1,4-dioxin-5,7-diyl)bis[N,N-bis(4-methoxyphenyl)-benzenamine] | C46H40N2O6S |
| 1622173-72-1 | Cinacalcet Impurity 50 HCl;N-(1-(7,8-dihydronaphthalen-1-yl)ethyl)-3-(3-(trifluoromethyl)phenyl)propan-1-amine hydrochloride | C22H25ClF3N |
| 1622848-92-3 | (S)-5-Benzyl-N-(5-methyl-4-oxo-2,3,4,5-tetrahydrobenzo[b][1,4]oxazepin-3-yl)-4H-1,2,4-triazole-3-carboxamide;3-(Phenylmethyl)-N-[(3S)-2,3,4,5-tetrahydro-5-methyl-4-oxo-1,5-benzoxazepin-3-yl]-1H-1,2,4-triazole-5-carboxamide | C20H19N5O3 |
| 1622849-58-4 | 5-(Phenylmethyl)-N-[(3S)-2,3,4,5-tetrahydro-5-methyl-4-oxo-1,5-benzoxazepin-3-yl]-3-isoxazolecarboxamide | C21H19N3O4 |
| 1622921-15-6 | 4-[2-(2-Cyclopentylidenehydrazinyl)-4-thiazolyl]benzonitrile hydrobromide | C15H14N4S.HBr |
| 1622928-68-0 | 1-Methoxy-4-oxocyclohexane-1-carboxylic acid | C8H12O4 |
| 1623101-11-0 | 3-Chloro-N-[3-chloro-4-(4-chloro-1,3-dihydro-1,3-dioxo-2H-isoindol-2-yl)phenyl]-2-pyridinecarboxamide | C20H10Cl3N3O3 |
| 1624117-53-8 | N-2-Naphthalenyl-N'-[2-oxo-2-(1-pyrrolidinyl)ethyl]urea | C17H19N3O2 |
| 1624294-38-7 | N-(3-Ethenylphenyl)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine hydrochloride (1:1) | C22H25N3O4.HCl |
| 1624602-30-7 | 7-Chloro-4-[4-[(2,4-dinitrophenyl)sulfonyl]-1-piperazinyl]quinoline | C19H16ClN5O6S |
| 1624970-54-2 | 4',4''',4''''',4'''''''-(1,2-Ethenediylidene)tetrakis[1,1'-biphenyl]-4-carboxaldehyde | C54H36O4 |
| 1626387-80-1 | (2R)-2,4-Dimethyl-1-piperazinecarboxylic acid 4-[(3-chloro-2-fluorophenyl)amino]-7-methoxy-6-quinazolinyl ester | C22H23ClFN5O3 |
| 1627091-47-7 | MLi-2-Bio-X;(2R,6S)-2,6-dimethyl-4-[6-[5-(1-methylcyclopropyl)oxy-1H-indazol-3-yl]pyrimidin-4-yl]morpholine | C21H25N5O2 |
| 1627494-13-6 | 8-[(1R)-1-[(3,5-Difluorophenyl)amino]ethyl]-N,N-dimethyl-2-(4-morpholinyl)-4-oxo-4H-1-benzopyran-6-carboxamide;AZD 8186 | C24H25F2N3O4 |
| 1627503-67-6 | 1-[4-[6-Methyl-5-(3,4,5-trimethoxyphenyl)-3-pyridinyl]phenyl]piperazine | C25H29N3O3 |
| 1627676-59-8 | 8-Fluoro-1,2,3,4-tetrahydro-N-[(1R)-2-oxo-2-(1-pyrrolidinyl)-1-[[3-(trifluoromethyl)phenyl]methyl]ethyl]-6-isoquinolinesulfonamide | C23H25F4N3O3S |
| 1627696-51-8 | (3R)-3-(5-Fluoro-4-pyrimidinyl)-2,3-dihydro-3-methyl-6-(1H-pyrazol-4-yl)-1H-isoindol-1-one | C16H12FN5O |
| 1627710-50-2 | 2,6-Difluoro-4-[4-[4-(4-methyl-1-piperazinyl)phenyl]-3-pyridinyl]phenol | C22H21F2N3O |
| 1627824-09-2 | N-[(R)-(2,3,4,5,6-Pentafluorophenoxy)phenoxyphosphinyl]-D-alanine 1-methylethyl ester | C18H17F5NO5P |
| 1627917-17-2 | Benzo[b]naphtho[2,3-d]furan-2-ylboronic acid | C16H11BO3 |
| 1627929-55-8 | PLX51107;(S)-4-(6-(3,5-dimethylisoxazol-4-yl)-1-(1-(pyridin-2-yl)ethyl)-1H-pyrrolo[3,2-b]pyridin-3-yl)benzoic acid | C26H22N4O3 |
| 1628047-84-6 | 4-Bromo-2-(1H-pyrrolo[2,3-b]pyridin-5-yloxy)benzoic acid 1,1-dimethylethyl ester;tert-butyl 4-bromo-2-(1H-pyrrolo[2,3-b]pyridin-5-yloxy)benzoate | C18H17BrN2O3 |
| 1628047-87-9 | 1-[[2-(4-Chlorophenyl)-4,4-dimethyl-1-cyclohexen-1-yl]methyl]piperazine dihydrochloride;1-((4'-Chloro-5,5-dimethyl-3,4,5,6-tetrahydro-[1,1'-biphenyl]-2-yl)methyl)piperazine dihydrochloride | C19H27ClN2.2(HCl) |
| 1628208-23-0 | 4,7-Dihydro-6-(1-methylethyl)-7-oxo-5-phenylpyrazolo[1,5-a]pyrimidine-3-carbonitrile;CPI 455 | C16H14N4O |
| 1628260-79-6 | 2-[[2-Ethyl-6-[4-[2-(3-hydroxy-1-azetidinyl)-2-oxoethyl]-1-piperazinyl]-8-methylimidazo[1,2-a]pyridin-3-yl]methylamino]-4-(4-fluorophenyl)-5-thiazolecarbonitrile | C30H33FN8O2S |
| 1628265-17-7 | 2-Chloro-4-(4-fluorophenyl)thiazole-5-carbonitrile | C10H4ClFN2S |
| 1628316-74-4 | 5-[[4-[[6-(2,2,2-Trifluoroethyl)thieno[2,3-d]pyrimidin-4-yl]amino]-1-piperidinyl]methyl]-1H-indole-2-carbonitrile;MI 136 | C23H21F3N6S |
| 1628317-18-9 | 4-Methyl-5-[[4-[[6-(2,2,2-trifluoroethyl)thieno[2,3-d]pyrimidin-4-yl]amino]-1-piperidinyl]methyl]-1H-indole-2-carbonitrile;MI 463 | C24H23F3N6S |
| 1628431-65-1 | 4-Amino-2-cyanobenzoic acid methyl ester | C9H8N2O2 |
| 1628639-06-4 | Olopatadine USP Related Compound A;Alpha-Hydroxy Olopatadine; (Z)-2-(11-(3-(dimethylamino)propylidene)-6,11-dihydrodibenzo[b,e]oxepin-2-yl)-2-hydroxyacetic acid | C21H23NO4 |
| 1628732-62-6 | Olinciguat;(2R)-3,3,3-trifluoro-2-[[[5-fluoro-2-[1-[(2-fluorophenyl)methyl]-5-(1,2-oxazol-3-yl)pyrazol-3-yl]pyrimidin-4-yl]amino]methyl]-2-hydroxypropanamide | C21H16F5N7O3 |
| 1628752-98-6 | 10-(4-(4,6-Diphenyl-1,3,5-triazin-2-yl)phenyl)-9,9-dimethyl-9,10-dihydroacridine;DMAC-TRZ | C36H28N4 |